Rorine International Holding Corp. (RIHC) financial statements (2022 and earlier)
Company profile
| Business Address |
7582 LAS VEGAS BLVD SOUTH LAS VEGAS, NV 89123 |
| State of Incorp. | NV |
| Fiscal Year End | November 30 |
| SIC | 3842 - Orthopedic, Prosthetic, and Surgical Appliances and Supplies (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in thousands)
| 11/30/2018 | 11/30/2017 | 11/30/2016 | 11/30/2015 | 11/30/2014 | 11/30/2013 | 11/30/2012 | |||
|---|---|---|---|---|---|---|---|---|---|
| ASSETS | |||||||||
| Current Assets | |||||||||
| Cash, cash equivalents, and short-term investments | 10 | ||||||||
| Cash and cash equivalents | 10 | ||||||||
| Deposits current assets | 2 | ||||||||
| Other undisclosed current assets | (2) | ||||||||
| Total current assets: | 10 | ||||||||
| Noncurrent Assets | |||||||||
| Property, plant and equipment | 24 | ||||||||
| Other undisclosed noncurrent assets | 2 | ||||||||
| Total noncurrent assets: | 26 | ||||||||
| TOTAL ASSETS: | 36 | ||||||||
| LIABILITIES AND EQUITY | |||||||||
| Liabilities | |||||||||
| Current Liabilities | |||||||||
| Accounts payable and accrued liabilities | 5 | 5 | 5 | 4 | 7 | 17 | 9 | ||
| Accounts payable | 5 | 5 | 5 | 4 | 7 | 17 | 9 | ||
| Due to related parties | 294 | 273 | 230 | 194 | 143 | ||||
| Deferred revenue and credits | ✕ | 1 | |||||||
| Other undisclosed current liabilities | 97 | 150 | |||||||
| Total current liabilities: | 299 | 279 | 235 | 198 | 150 | 114 | 161 | ||
| Noncurrent Liabilities | |||||||||
| Total liabilities: | 299 | 279 | 235 | 198 | 150 | 114 | 161 | ||
| Stockholders' equity | |||||||||
| Stockholders' equity attributable to parent, including: | (299) | (279) | (235) | (198) | (150) | (114) | (125) | ||
| Preferred stock | 1 | 1 | 1 | 1 | 1 | 1 | 1 | ||
| Common stock | 24 | 24 | 24 | 24 | 24 | 24 | 24 | ||
| Additional paid in capital | 7,646 | 7,646 | 7,646 | 6,793 | 6,793 | 6,793 | 6,586 | ||
| Accumulated other comprehensive loss | (0) | ||||||||
| Accumulated deficit | (7,971) | (7,950) | (7,906) | (7,016) | (6,967) | (6,932) | (6,650) | ||
| Other undisclosed stockholders' equity attributable to parent | (85) | ||||||||
| Total stockholders' equity: | (299) | (279) | (235) | (198) | (150) | (114) | (125) | ||
| TOTAL LIABILITIES AND EQUITY: | 36 | ||||||||
Income statement (P&L) ($ in thousands)
| 11/30/2018 | 11/30/2017 | 11/30/2016 | 11/30/2015 | 11/30/2014 | 11/30/2013 | 11/30/2012 | ||
|---|---|---|---|---|---|---|---|---|
| Operating expenses | (21) | (44) | (37) | (48) | (36) | (59) | (146) | |
| Other undisclosed operating income (loss) | (854) | 39 | ||||||
| Operating loss: | (21) | (44) | (890) | (48) | (36) | (59) | (107) | |
| Net loss: | (21) | (44) | (890) | (48) | (36) | (59) | (107) | |
| Other undisclosed net loss attributable to parent | (144) | |||||||
| Net loss available to common stockholders, diluted: | (21) | (44) | (890) | (48) | (36) | (203) | (107) | |
Comprehensive Income ($ in thousands)
| 11/30/2018 | 11/30/2017 | 11/30/2016 | 11/30/2015 | 11/30/2014 | 11/30/2013 | 11/30/2012 | ||
|---|---|---|---|---|---|---|---|---|
| Net loss: | (21) | (44) | (890) | (48) | (36) | (59) | (107) | |
| Comprehensive loss: | (21) | (44) | (890) | (48) | (36) | (59) | (107) | |
| Other undisclosed comprehensive loss, net of tax, attributable to parent | (138) | (0) | ||||||
| Comprehensive loss, net of tax, attributable to parent: | (21) | (44) | (890) | (48) | (36) | (196) | (107) | |
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.